Low-Intensity Blood Stem Cell Transplants for Sickle Cell Disease May Help Improve Lung Function, Study Says

The low-intensity transplants also do not appear to damage the lungs, which marks a potential breakthrough, given historical treatments for sickle cell disease have health risks associated.

A new three-year study shows that “so-called low-intensity blood stem cell transplants, which use milder conditioning agents than standard stem cell transplants, do not appear to damage the lungs and may help improve lung function in some patients with sickle cell disease.” NIH has the release.

One of the leading causes of death in people with sickle cell disease is damage to lung tissue and worsened lung function. Using a low-intensity blood stem cell transplant, which “tend to be better tolerated by adults,” may help more people get treatment.

The only cure for sickle cell disease has historically been bone marrow and blood stem cell transplants, but “relatively few adults have undergone the treatments due to health risks associated with high doses of chemotherapy required to prepare for transplants. In addition, the process requires a genetically well-matched donor, usually a sibling who does not have SCD.”

At least one third of the sickle cell stem cell transplants are low-intensity, which are “slightly less effective than the standard transplants.” However, “adults who often have more pre-existing organ damage than children tend to do better with them and also experience a lower risk for complications such as graft-versus-host disease.”

Researchers conducted “a variety of pulmonary function tests” in 97 patients who underwent a low-intensity blood stem cell transplant. After three years, “overall lung function among the patients remained stable,” and measures like diffusing capacity of the lungs for carbon monoxide and six-minute walk distance “improved significantly following transplant.”

About the Author

Matt MacKenzie

Matt MacKenzie

Associate Editor

Matt MacKenzie is Senior Staff Writer and Associate Editor of Healthcare Purchasing News (HPN), where he leads daily news coverage and contributes in-depth features on healthcare supply chain, sterile processing, infection prevention and clinical operations. Through industry reporting and expert interviews, he examines the trends, technologies and operational challenges shaping healthcare purchasing and patient care. 

Sign up for our eNewsletters
Get the latest news and updates